Art
J-GLOBAL ID:200902217523533992   Reference number:09A0921474

Therapeutic antitumor efficacy of monoclonal antibody against Claudin-4 for pancreatic and ovarian cancers

膵臓癌および卵巣癌におけるクラウジン-4に対するモノクローナル抗体の治療的抗腫瘍効力
Author (10):
Material:
Volume: 100  Issue:Page: 1623-1630  Publication year: Sep. 2009 
JST Material Number: W1423A  ISSN: 1347-9032  Document type: Article
Article type: 原著論文  Country of issue: Australia (AUS)  Language: ENGLISH (EN)
Thesaurus term:
Thesaurus term/Semi thesaurus term
Keywords indexed to the article.
All keywords is available on JDreamIII(charged).
On J-GLOBAL, this item will be available after more than half a year after the record posted. In addtion, medical articles require to login to MyJ-GLOBAL.
,...
Semi thesaurus term:
Thesaurus term/Semi thesaurus term
Keywords indexed to the article.
All keywords is available on JDreamIII(charged).
On J-GLOBAL, this item will be available after more than half a year after the record posted. In addtion, medical articles require to login to MyJ-GLOBAL.

   To see more with JDream III (charged).   {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=09A0921474&from=J-GLOBAL&jstjournalNo=W1423A") }}
JST classification (3):
JST classification
Category name(code) classified by JST.
Experimental treatment for tumors  ,  Basic research of antitumor(=antineoplastic)drugs  ,  Production and application of antigens,antibodies,complements 
Reference (41):
  • American Cancer Society. Cancer facts and figures 2006. 2006
  • JAKOBOVITS, A. Monoclonal antibody therapy for prostate cancer. Handb Exp Pharmacol. 2008, 181, 237-256
  • CLYNES, RA. Inhibitory Fc receptors modulate in vivo cytoxicity against tumor targets. Nat Med. 2000, 6, 443-446
  • CARTRON, G. Therapeutic activity of humanized anti-CD20 monoclonal antibody and polymorphism in IgG Fc receptor FcRIIIa gene. Blood. 2002, 99, 754-758
  • GENNARI, R. Pilot study of the mechanism of action of preoperative trastuzumab in patients with primary operable breast tumors overexpressing HER2. Clin Cancer Res. 2004, 10, 5650-5655
more...

Return to Previous Page